Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-022-6 | CAS number: 473278-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral (OECD 423), rat: LD50 cut-off value = 5000 mg/kg bw
Inhalation (similar to OECD 403), rat: LC50 > 1.34 mg/L air
Dermal (OECD 402), rat: LD50 > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 340 mg/m³
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Additional information
Reliable studies on the potential for the test substance to cause acute oral, inhalation and dermal toxicity are available.
Oral:
The acute oral toxicity of the test substance was assessed in a study performed according to OECD Guideline 423 and in compliance with GLP (2004). A group of three fasted female Sprague-Dawley CD rats was treated with the test material at a dose level of 2000 mg/kg bw. This was followed by a further group of three fasted females treated with the same dose level. The test material was administered by gavage as a suspension in arachis oil BP. The animals were observed for 14 days. There were no deaths and all the animals showed the expected gains in bodyweight over the study period. Hunched posture was noted in one animal during the day of dosing. Five animals appeared normal throughout the study and the remaining animal appeared normal one day after dosing. No abnormalities were detected at necropsy.
The acute oral LD50 cut-off of the test material (as defined in the OECD GL 423) was 5000 mg/kg bw.
Inhalation:
The acute inhalation toxicity of the test substance was assessed in a study similar to OECD Guideline 403 and performed in compliance with GLP (2004). A group of 10 Sprague-Dawley rats (5/sex) was exposed to the test substance as a dust. The animals were exposed for four hours using a nose-only exposure system, followed by a fourteen-day observation period. The mean achieved atmosphere concentration was 1.34 mg/mL which was the mean maximum attainable concentration. The mean mass median aerodynamic diameter was 4.84 µm with a geometric standard deviation of 2.77. No animal died during this study and all the animals showed normal bodyweight development. Common abnormalities noted in all the animals until 1 h after exposure ended, included increased respiratory rate, hunched posture, pilo-erection and wet fur and there were an isolated instance of fur staining by the test material. Four of six animals recovered quickly to appear normal by day 1, while an increased respiratory rate and hunched posture persisted in 2/6 animals and gradually became less severe until Day 5 post-exposure. No abnormalities were detected at necropsy.
The acute inhalation LC50 was considered to be greater than 1.34 mg/L air (analytical).
Dermal:
The acute dermal toxicity of the test substance was assessed in a study performed according to OECD Guideline 402 and in compliance with GLP (2004). A group of ten animals (five males and five females Sprague Dawley rats) was given a single, 24-hour, semi-occluded dermal application of the test material to intact skin at a dose level of 2000 mg/kg bodyweight. The animals were observed for 14 days. There were no deaths and all the animals showed the expected gains in bodyweight over the study period. No signs of systemic toxicity and no signs of dermal irritation were observed. No abnormalities were noted at necropsy.
The acute dermal LD50 of the test material was found to be greater than 2000 mg/kg bw.
This finding is further supported by a supporting study done similar to OECD Guideline 402 but not in compliance with GLP. There was no mortality, and no clinical signs of toxicity were observed. No skin irritation was noted at the test site and not treatment-related changes were observed at necropsy. In this study a LD50 of greater than 2000 mg/kg bw was observed.
Justification for classification or non-classification
The available data on acute oral, inhalation and dermal toxicity do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
